76 related articles for article (PubMed ID: 2277941)
1. [Acquired genetic abnormalities in cancer of the breast].
Lidereau R
Rev Prat; 1990 Nov; 40(26):2468-72. PubMed ID: 2277941
[No Abstract] [Full Text] [Related]
2. The genetics of sporadic breast cancer.
Brenner AJ; Aldaz CM
Prog Clin Biol Res; 1997; 396():63-82. PubMed ID: 9108590
[TBL] [Abstract][Full Text] [Related]
3. Gene and chromosomal alterations in sporadic breast cancer: correlation with histopathological features and implications for genesis and progression.
Tsuda H
Breast Cancer; 2009; 16(3):186-201. PubMed ID: 19472036
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
[TBL] [Abstract][Full Text] [Related]
5. BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability.
Gretarsdottir S; Thorlacius S; Valgardsdottir R; Gudlaugsdottir S; Sigurdsson S; Steinarsdottir M; Jonasson JG; Anamthawat-Jonsson K; Eyfjörd JE
Cancer Res; 1998 Mar; 58(5):859-62. PubMed ID: 9500438
[TBL] [Abstract][Full Text] [Related]
6. [Oncogenes and anti-oncogenes in breast cancer].
Birnbaum D; Gaudray P
Bull Cancer; 1989; 76(7):677-87. PubMed ID: 2573395
[TBL] [Abstract][Full Text] [Related]
7. Oncogenes and tumour suppressor genes in breast cancer.
Eccles MR; Phipps RF
Br J Hosp Med; 1993 Nov 3-16; 50(9):529-36. PubMed ID: 7904528
[TBL] [Abstract][Full Text] [Related]
8. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
[TBL] [Abstract][Full Text] [Related]
9. Chromosome 11q13 abnormalities in human breast cancer.
Fantl V; Smith R; Brookes S; Dickson C; Peters G
Cancer Surv; 1993; 18():77-94. PubMed ID: 8013002
[TBL] [Abstract][Full Text] [Related]
10. A molecularly genetic determination of prognostic factors of the prostate cancer and their relationships to expression of protein p27kip1.
Dvorácková J; Uvírová M
Neoplasma; 2007; 54(2):149-54. PubMed ID: 17319789
[TBL] [Abstract][Full Text] [Related]
11. Oncogene amplification and chromosomal abnormalities in small cell lung cancer.
Ibson JM; Waters JJ; Twentyman PR; Bleehen NM; Rabbitts PH
J Cell Biochem; 1987 Apr; 33(4):267-88. PubMed ID: 3034934
[TBL] [Abstract][Full Text] [Related]
12. Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis.
Varley JM; Swallow JE; Brammar WJ; Whittaker JL; Walker RA
Oncogene; 1987; 1(4):423-30. PubMed ID: 3330785
[TBL] [Abstract][Full Text] [Related]
13. Significance of HER2 and C-MYC oncogene amplifications in breast cancer in atomic bomb survivors: associations with radiation exposure and histologic grade.
Miura S; Nakashima M; Ito M; Kondo H; Meirmanov S; Hayashi T; Soda M; Matsuo T; Sekine I
Cancer; 2008 May; 112(10):2143-51. PubMed ID: 18348306
[TBL] [Abstract][Full Text] [Related]
14. High levels of c-myc protein in human breast tumours determined by a sensitive ELISA technique.
Spandidos DA; Field JK; Agnantis NJ; Evan GI; Moore JP
Anticancer Res; 1989; 9(4):821-6. PubMed ID: 2683996
[TBL] [Abstract][Full Text] [Related]
15. Two distinct regions involved in 1p deletion in human primary breast cancer.
Bièche I; Champème MH; Matifas F; Cropp CS; Callahan R; Lidereau R
Cancer Res; 1993 May; 53(9):1990-4. PubMed ID: 8097672
[TBL] [Abstract][Full Text] [Related]
16. Proto-oncogene amplification and human breast tumor phenotype.
Adnane J; Gaudray P; Simon MP; Simony-Lafontaine J; Jeanteur P; Theillet C
Oncogene; 1989 Nov; 4(11):1389-95. PubMed ID: 2554239
[TBL] [Abstract][Full Text] [Related]
17. Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers.
Riou G; Barrois M; Sheng ZM; Duvillard P; Lhomme C
Oncogene; 1988 Sep; 3(3):329-33. PubMed ID: 3060795
[TBL] [Abstract][Full Text] [Related]
18. [Risk assessment for familial occurrence of breast cancer].
Chang-Claude J; Becher H; Hamann U; Schroeder-Kurth T
Zentralbl Gynakol; 1995; 117(8):423-34. PubMed ID: 7571905
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetics in obstetrics and gynecology.
Mark HF; Lathrop J
Med Health R I; 1996 Feb; 79(2):55-7. PubMed ID: 8907152
[No Abstract] [Full Text] [Related]
20. Relations of the c-myc gene and chromosome 8 in non-small cell lung cancer: analysis by fluorescence in situ hybridization.
Kubokura H; Tenjin T; Akiyama H; Koizumi K; Nishimura H; Yamamoto M; Tanaka S
Ann Thorac Cardiovasc Surg; 2001 Aug; 7(4):197-203. PubMed ID: 11578259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
